Spectrum Vascular
NY - White PlainsBiotechnology
Focus: Spectrum Vascular is an early-stage biotech founded in 2023 specializing in vascular access devices with antimicrobial protection and thrombus reduction technologies. The company operates in the niche medical device space targeting infectious disease and cardiovascular indications.
Profile data last refreshed 6h ago · AI intelligence enriched 2w ago
Open Jobs
6-3 this month
Stable — net -3 jobs in 30d
2 added, 5 removed. Backfill posture.
Should You Work at Spectrum Vascular?
AI assessmentHigh-risk, high-reward early-stage play best suited for entrepreneurial professionals comfortable with uncertainty and willing to build infrastructure from scratch.
Why Work Here
- Ground-floor opportunity at a newly founded (2023) company with focused technology in high-need vascular access market
- Active hiring across Commercial (4 roles), Supply Chain (3), and Manufacturing (2) suggests company is transitioning from development to commercialization
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Recent News · Spectrum Vascular(1)
Help build intelligence for Spectrum Vascular
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.